Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01709734
Title A 2 Part, Phase 2 Trial of Galeterone in the Treatment of Castration Resistant Prostate Cancer
Recruitment Completed
Gender male
Phase Phase II
Variant Requirements No
Sponsors Tokai Pharmaceuticals
Indications

prostate adenocarcinoma

Therapies

Galeterone

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.